Sylvia Louisa G, Montana Rebecca E, Deckersbach Thilo, Thase Michael E, Tohen Maurcio, Reilly-Harrington Noreen, McInnis Melvin G, Kocsis James H, Bowden Charles, Calabrese Joseph, Gao Keming, Ketter Terence, Shelton Richard C, McElroy Susan L, Friedman Edward S, Rabideau Dustin J, Nierenberg Andrew A
Department of Psychiatry, Massachusetts General Hospital, 50 Staniford Street, Suite 580, Boston, MA, 02114, USA.
Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.
Int J Bipolar Disord. 2017 Dec;5(1):10. doi: 10.1186/s40345-017-0078-4. Epub 2017 Mar 27.
This study explores the association of demographic and clinical features with quality of life and functioning in individuals with bipolar disorder.
Adult participants (N = 482) with bipolar I or II disorder were enrolled in a comparative effectiveness study across eleven study sites and completed baseline measures of medical and psychiatric history, current mood, quality of life, and functioning. Participants with at least mildly depressive or manic/hypomanic symptomatic severity were randomized to receive lithium or quetiapine in addition to adjunctive personalized treatment for 6 months.
Participants with more severe depressive and irritability symptoms had lower quality of life and higher functional impairment. All psychiatric comorbid conditions except substance use disorder were associated with worse quality of life. On average, females had lower quality of life than males. Patients who were married, living as married, divorced, or separated had worse functional impairment compared with patients who were single or never married. A composite score of social disadvantage was associated with worse functioning and marginally associated with worse quality of life. Symptom severity did not moderate the effect of social disadvantage on quality of life or functioning.
Our findings highlight that depression, irritability, and psychiatric comorbid conditions negatively impact quality of life and functioning in bipolar disorder. The study suggests that individuals with social disadvantage are at risk for functional impairment. Trial Registration This study is registered with ClinicalTrials.gov. Identification number: NCT01331304.
本研究探讨双相情感障碍患者的人口统计学和临床特征与生活质量及功能的关联。
患有双相I型或II型障碍的成年参与者(N = 482)在11个研究地点参与了一项比较疗效研究,并完成了医学和精神病史、当前情绪、生活质量及功能的基线测量。症状严重程度至少为轻度抑郁或躁狂/轻躁狂的参与者被随机分配接受锂盐或喹硫平治疗,同时接受为期6个月的辅助个性化治疗。
抑郁和易怒症状更严重的参与者生活质量较低,功能损害较高。除物质使用障碍外,所有精神共病情况均与较差的生活质量相关。平均而言,女性的生活质量低于男性。已婚、同居、离婚或分居的患者与单身或从未结婚的患者相比,功能损害更严重。社会劣势综合评分与较差的功能相关,与较差的生活质量存在边缘关联。症状严重程度并未调节社会劣势对生活质量或功能的影响。
我们的研究结果表明,抑郁、易怒和精神共病情况对双相情感障碍患者的生活质量和功能有负面影响。该研究表明,处于社会劣势的个体存在功能损害风险。试验注册 本研究已在ClinicalTrials.gov注册。识别号:NCT01331304。